Orthopaedics

FloraSeal®

Surgical Site Infections (SSI) have been shown to increase Arthroplasty costs by 61%[1] and it is estimated that 2% to 5% of all patients who undergo surgery will develop a SSI.[2]
The median cost of treating Prosthetic Joint Infection is $34,800 per patient[3] with infection shown as the cause of 17% of Revision Hips and 24.1% of Revision Knees[4]

FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[5]
FloraSeal effectively reduces microbial colonisation within 15 minutes and maintains a low microbial colonisation throughout the 24 hours after application, has the same efficacy when being used with or without an antimicrobial surgical incise drape, and mitigates microorganisms more effectively than an antimicrobial surgical incise drape alone.[6]

1. Peel, T.N., Cheng, A.C., Liew, D., Buising, K.L., Lisik, J., Carroll, K.A., Choong, P.F.M. and Dowsey, M.M. (2015), Direct Hospital Cost Determinants Following Hip and Knee Arthroplasty. Arthritis Care & Research, 67: 782-790. https://doi.org/10.1002/acr.22523

2. Towfigh, S., Cheadle, W. G., Lowry, S. F., Malangoni, M. A., & Wilson, S. E. (2008). Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Archives of surgery (Chicago, Ill.:1960), 143(9), 885–891.

3. Peel, T. N., Cheng, A. C., Lorenzo, Y. P., Kong, D. C., Buising, K. L., & Choong, P. F. (2013). Factors influencing the cost of prosthetic joint infection treatment. The Journal of hospital infection, 85(3), 213–219. https://doi.org/10.1016/j.jhin.2013.07.012

4. AOANJRR 2020. https://aoanjrr.sahmri.com/documents/10180/689619/Hip%2C+Knee+%26+Shoulder+Arthroplasty+New/6a07a3b8-8767-06cf-9069-d165dc9baca7

5. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

6. Data on File. HB Fuller - Medical Adhesives Technology

SurgiSeal®

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.

1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

Synvichor™

Synvichor is the world’s first genomic PCR test that sets a new medical standard globally for the rapid, accurate and reliable differentiation of joint pain.

Undifferentiated joint pain: a global problem

When a patient presents with a red, hot, swollen and painful joint, reliably differentiating infection from inflammation poses a significant global problem.

Typical wait times for culture results vary from 24hrs to 21 days, with a true positivity of up to 20%, meaning they are inconclusive more than 80% of the time.

Rather than risk missing or misdiagnosing an infection, the current approach sees the patient admitted to hospital and treated with antibiotics.

This results in uncertainty for patients and clinicians, increased costs to the hospital, and poorer outcomes.

Unparalleled speed, precision, and reliability

With up to 95% negative and positive predictive value and results in ~3 hours, Synvichor provides rapid and reliable differentiation of joint pain.

Synvichor helps to rapidly assess which patients require urgent treatment for infection, and which patients can be safely managed in the community for non-infectious inflammation.

Enhances your diagnostic speed

Optimises your treatment options

Enables clinicians to safely manage up to two-thirds of patients in the community

RAPID RESULTS

~ 3 hours

vs current culture testing

24 hours - 21 days

RELIABLE PRECISION

UP TO

95%

ACCURACY

vs current culture testing

13-20% accuracy[1]

2. Graue C et al. Open Forum Infect Dis. 2020; 7(Suppl 1):S233–4.

Medtronic RF Ablation

The Accurian™ Radiofrequency Ablation (RFA) platform combines proprietary hardware design and quad core processing, resulting in sophisticated algorithms that manage power and control temperature during ablation surgery. The Accurian™ Radiofrequency Ablation (RFA) therapy platform has been extensively tested for lasting reliability and is upgrade-ready for the future.

Internally cooled probes create larger, spherical lesions (compared to standard lesions) with greater distal projection.

Larger spherical lesions (compared with standard lesions)
Flexibility in approach angle with enhanced probes: as much as 45% of lesion volume is projected distally to probe tip

PROCEDURES

Knee OA/Pain
Hip OA/Pain
Shoulder OA/Pain

Aquamantys™

Shown to reduce blood loss by 40% in THA and decrease transfusions by 73%[7]
Improves maintenance of haemoglobin levels compared to traditional electrosurgery[7,8]
Reduces post-operative drainage compared to traditional electrosurgery[8]
Reduces transfusion rates[7,8,9]
Reduces length of stay following THA[9]

Increases the percentage of patients discharged home after THA[9,10]
Has been shown to reduce the incidence of haematoma, one of the top three reasons for TJA readmission, by 75% in THA[8,9]
Has been shown to reduce post-operative pain and swelling leading to a reduced incidence of hemarthrosis following TKA[11]
Has been shown to reduce operative time during infected THA revisions[12]

PROCEDURES

Total knee arthroplasty
Total hip arthroplasty
Total shoulder arthroplasty
Revision orthopaedic surgery
Amputation
Trauma

7. Marulanda GA,Ulrich SD, Seyler TM, Delanois RE, Mont MA. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008;5(2):125–131.

7. Marulanda GA,Ulrich SD, Seyler TM, Delanois RE, Mont MA. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008;5(2):125–131.
8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.
9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.
10. Nichols C, Vose J. Clinical Outcomes and Costs Within 90 days of Primary or Revision Total Joint Arthroplasty. Arthroplasty 2016;Epub ahead of print.

8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.
9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

11. Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty 2007;22(4 Suppl 1):82–85.

12. Clement RC, Derman PB, Graham DS, Speck RM, Flynn DN, Levin LS, Fleisher LA. Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty. J Arthroplasty. 2013 Sep;28(8 Suppl):7-10.

PlasmaBlade™

Single skin-to-skin instrument eliminates device exchanges, and as a result, the risk of scalpel injuries incurred during exchanges[13,14]
Compared to scalpel and traditional electrosurgery, the PlasmaBlade™ has demonstrated a 12% reduction in operative time during total knee arthroplasty[13]
Comparable blood loss to scalpel and traditional electrosurgery,[13] with reduced thermal injury compared to traditional electrosurgery[15]

PROCEDURES

Total knee arthroplasty
Total hip arthroplasty
Total shoulder arthroplasty
Patients with pacemaker, DBS, or spine stimulator insitu

13. Data on file. VR-00083 study summary. 71-10-2454.
14. Vose JG, McAdara-Berkowitz J. Reducing scalpel injuries in the operating room. AORN J. 2009;90(6):867-872.

13. Data on file. VR-00083 study summary. 71-10-2454.

15. Ruidiaz ME, Messmer D, Atmodjo DY, et al. Comparative healing of human cutaneous surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a standard scalpel. Plast Reconstr Surg. 2011;128(1):104-111.

RadiaLux™

The RadiaLux™ lighted retractor is a single-use retractor designed to provide surgeons with the ability to manipulate soft tissue through a combination of blades when assembled onto a retractor handle.
The retractor provides illumination to the surgical field independent of an external light source or fibre optic cables.
The lighted retractor is indicated for enhancing visibility to a surgical field through retraction of soft tissue and illumination of the surgical cavity.

Negative Pressure Wound Therapy

According to a recent review, application of a single-use negative pressure wound therapy system reduced the rate of SSI by 58% compared to standard of care. Additionally, patients had less hospital LOS compared to standard of care.[1]

The Genadyne NPWT portfolio is completely comprehensive, from Ultraportable Single-Use and Reusable Pumps to High Demand and Instil Pumps. The Dressing Portfolio is compatible across all NPWT Pumps, allowing for an all-inclusive ecosystem for a hospital institution. From Absorbent Dressings that can be used with or without NPWT, ready to use Foam Dressings, and all the way to large Foam Kits, Abdominal Kits and PVA Kits.

Closed incision management negative pressure has been proven to:

Protect the incision from external contamination
Hold closed incision wound edges together
Help reduce tensile forces across the incision
Help reduce oedema
Reduce seroma and haematoma fluid collection
Suitable for dehisced wounds, trauma wounds, partial thickness burns, flaps and grafts

Green Foam

More than just a colour…

The visual impact of the Genadyne Green Foam is undeniable. Green was chosen to allow clinicians to better differentiate between viable and nonviable tissue in the wound bed. The colour contrast increases differentiation with the wound bed.

Competitor

Patented Genadyne Green Foam

Genadyne Green Foam is a fully reticulated polyurethane foam made with polyether resin to allow better hydrolytic stability. The design increases performance under pressure and in moist environments.
The Dodecahedron cell structure gives a three-dimensional skeletal strand to the cells providing enhanced filtering qualities and increasing the removal of exudate and infectious materials. This cell structure also increases tensile strength to prevent fraying. Fraying is significantly reduced, preventing stray pieces from being left in the wound bed.
The combination of cell structure and composition gives the foam a non-adherent property, allowing for easier removal during dressing changes, thereby reducing pain and discomfort.
The foam creates direct contact with the wound bed, allowing for even distribution of pressure. This assists in reducing oedema and promotes tissue perfusion and granulation.

Properties

Benefits

Fully reticulated polyurethane foam

Increased hydrolytic stability

Polyether resin

Increased tensile strength

Pore Size

Boosts performance under pressure

Dodecahedron cell structure / 3 dimensional skeletal strands

Enhanced filtering qualities
Increased tensile strength
Reduced risk of fraying
Non-adherent properties
Reduced discomfort during dressing change

Variable Pressure

The advanced variable pressure capabilities of all of the Genadyne Negative Pressure Pumps, allow different negative pressures to be used without the downsides of painful intermittent therapy.

By maintaining negative pressure throughout the cycle, variable negative pressure wound therapy avoids losing an airtight seal and displacement of the dressing. This gradual “wave” is gentler to the patient increasing blood flow to the peri-wound and preventing ischemia. The changes in pressure are imperceptible to the patient, increasing patient comfort and compliance.

The literature suggests that the use of Variable Pressure is beneficial. It results in decreased blood flow that is known to stimulate angiogenesis and granulation tissue formation and to increase blood flow that is known to facilitate oxygenation and nutrient supply and removal of waste products. [2]

Cycling the negative pressure level may be beneficial especially when treating poorly vascularized tissue with a risk for development of ischemia, as pressure is released repeatedly.[2]

1. Sugrue M, Ciprandi G, Djohan R, et al. . World Union of Wound Healing Societies (WUWHS) Consensus Document. Closed surgical incision management: Understanding the role of NPWT. Wounds Int [Internet]. 2016. www.woundsinternational.com/wuwhs/view/consensus-document-closed-surgica... (Last accessed July 29, 2017)

2. Ola Borgquist, MD; Richard Ingemansson, MD, PhD; and Malin Malmsjö, MD, PhD (2010) The Effect of Intermittent and Variable Negative Pressure Wound Therapy on Wound Edge Microvascular Blood Flow

1300 533 699

Revolution Surgical Pty Ltd
4/22 Rowood Road, Prospect NSW 2148
ABN: 63 165 643 434

info@revolution-surgical.com

Website by: